René Adam

TL;DR: This overview discusses the reported resection rates for biological agents combined with chemotherapy and the difficulties of cross-trial comparisons, the pre-, peri- and postoperative roles of biological agents, particularly with regards to comparisons of surgical complications, and ongoing clinical trials in which the resectability of CLMs is a predefined end point.

TL;DR: IGL-1 protection was associated with a reduced liver damage, higher induced autophagy and decreased apoptosis, which would contribute to limit the subsequent extension of reperfusion injury after graft revascularization in liver transplantation procedures.

TL;DR: Not only were the results of the original analysis confirmed by multivariate analysis but additional analyses excluding German centers and living donor liver transplants, also conveyed the same message.

TL;DR: Immunological circadian rhythms appear to be maintained in liver transplant patients receiving continuous infused immunosuppressive therapy, however, rhythms were altered in patients with advanced stage malignancy or HIV infection, and in cancer patients receiving infusions of cytokines on a standard regimen.